Comprehensive Adrenergic Blockade Post Myocardial Infarction Left Ventricular Dysfunction

Cardiology Clinics

Volumn 26, Issue 1, 2008, Pages 79-89

  Fonarow, Gregg C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; NITRATE; PLACEBO; PROPRANOLOL; TIMOLOL; TRANDOLAPRIL;

ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EVIDENCE BASED MEDICINE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 39649091202     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2007.08.006     Document Type: Review

References (34)

1. American Heart Association. Heart disease and stroke statistics-2007 update (2007), American Heart Association, Dallas (TX)
2. Solomon S.D., Zelenkofske S., McMurray J.J., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 25 (2005) 2581-2588
3. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110 (2004) 588-636
4. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdf. Accessed: March 16, 2007.
5. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction: Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333 (1995) 1670-1676
6. Cleland J.G., Torabi A., and Khan N.K. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart 91 Suppl 2 (2005) ii7-ii13
7. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247 (1982) 1707-1714
8. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304 (1981) 801-807
9. CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357 (2001) 1385-1390
10. ISIS-1 Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 2 (1986) 57-66
11. Lopressor Intervention Trial Research Group. The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group. Eur Heart J 8 (1987) 1056-1064
12. Wu A.H., Parsons L., Every N.R., et al. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 40 (2002) 1389-1394
13. Hasdai D., Topol E.J., Kilaru R., et al. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. Am Heart J 145 (2003) 73-79
14. Steg P.G., Dabbous O.H., Feldman L.J., et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 109 (2004) 494-499
15. Wang T.J., Levy D., Benjamin E.J., et al. The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 138 (2003) 907-916
16. Weir R., and McMurray J.J. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction. Heart 91 Suppl 2 (2005) ii17-ii20
17. Fonarow G.C. The management of the diabetic patient with prior cardiovascular events. Rev Cardiovasc Med 4 Suppl 6 (2003) S38-S49
18. Hjalmarson A., Herlitz J., Holmberg S., et al. The Goteborg metoprolol trial: effects on mortality and morbidity in acute myocardial infarction. Circulation 67 (1983) I26-I32
19. MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. The MIAMI Trial Research Group. Eur Heart J 6 (1985) 199-226
20. Freemantle N., Cleland J., Young P., et al. Beta-blockade after myocardial infarction: systematic review and meta-regression analysis. BMJ 318 (1999) 1730-1737
21. Roberts R., Rogers W.J., Mueller H.S., et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation 83 (1991) 422-437
22. Chen Z.M., Pan H.C., Chen Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1622-1632
23. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. JAMA 250 (1983) 2814-2819
24. Sackner-Bernstein J.D. New evidence from the CAPRICORN trial: the role of carvedilol in high-risk, post-myocardial infarction patients. Rev Cardiovasc Med 4 Suppl 3 (2003) S25-S29
25. COREG and COREG CR (carvedilol) tablets [prescribing information]. Research Triangle Park, NC, GlaxoSmithKline; 2006.
26. Lopez-Sendon Hentsch J., Dargie H., Remme W., et al. Effect of carvedilol on mortality and reinfarction in left ventricular dysfunction after infarction: a subgroup analysis from CAPRICORN study. Eur Heart J 4 (2002) 396
27. Doughty R.N., Whalley G.A., Walsh H.A., et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 109 (2004) 201-206
28. Packer M. Do beta-blockers prolong survival in heart failure only by inhibiting the beta-1-receptor? A perspective on the results of the COMET trial. J Card Fail 9 (2003) 429-443
29. Fonarow G.C. Practical considerations of beta-blockade in the management of the post-myocardial infarction patient. Am Heart J 149 (2005) 984-993
30. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure: MOCHA investigators. Circulation 94 (1996) 2807-2816
31. Willenheimer R., van Veldhuisen D.J., Silke B., et al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 112 (2005) 2426-2435
32. Sliwa K., Norton G.R., Kone N., et al. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. J Am Coll Cardiol 44 (2004) 1825-1830
33. Becker R.C., Burns M., Gore J.M., et al. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants. Am Heart J 135 (1998) 786-796
34. Jencks S.F., Huff E.D., and Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. JAMA 289 (2003) 305-312